Evidence map›Paper›PMID 24843127›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.

Chong Wee Liew, Anke Assmann, Andrew T Templin, Jeffrey C Raum, Kathryn L Lipson, Sindhu Rajan, Guifen Qiang, Jiang Hu, Dan Kawamori, Iris Lindberg and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Insulin regulates arginine-stimulated insulin secretion in humans.Metabolism: clinical and experimental · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in β cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  19. eIF4G1 and carboxypeptidase E axis dysregulation inThe Journal of biological chemistry · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Chong Wee LiewJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612; rohit.kulkarni@joslin.harvard.edu cwliew@uic.edu.
Anke AssmannJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;
Andrew T TemplinDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202;
Jeffrey C RaumDepartment of Medicine/Endocrinology, Diabetes, and Metabolism and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104;
Kathryn L LipsonProgram in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01605;
Sindhu RajanDepartment of Medicine, The University of Chicago, Chicago, IL 60637;
Guifen QiangDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612;
Jiang HuJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;
Dan KawamoriJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;
Iris LindbergDepartment of Anatomy and Neurobiology, University of Maryland, Baltimore, MD 21201;
Louis H PhilipsonDepartment of Medicine, The University of Chicago, Chicago, IL 60637;
Nahum SonenbergDepartment of Biochemistry, McGill University, Montreal, QC, Canada H3A 1A3; and.
Allison B GoldfineJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215;
Doris A StoffersDepartment of Medicine/Endocrinology, Diabetes, and Metabolism and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104;
Raghavendra G MirmiraDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202;
Fumihiko UranoDivision of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Rohit N KulkarniJoslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215; rohit.kulkarni@joslin.harvard.edu cwliew@uic.edu.
Harvard University · USUniversity of Chicago · USUniversity of Pennsylvania · USBrigham and Women's Hospital · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineMcGill University · CAUniversity of Illinois Chicago · USUniversity of Maryland, Baltimore · USUniversity of Massachusetts Chan Medical School · USWashington University in St. Louis · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI AHIMA, REXFORD S. · 1995 to 2016
$26.9M
TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
OPIOID PEPTIDE SYNTHESIZING ENZYMESR01DA005084 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDBERG, IRIS · 1988 to 2014
$4.4M
CONTROL OF PEPTIDE HORMONE BIOSYNTHESIS BY PC2 AND 7B2R01DK049703 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDBERG, IRIS · 1996 to 2012
$3.7M
Transcriptional Coregulators in Pancreas DevelopmentR01DK068157 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI STOFFERS, DORIS A · 2005 to 2013
$3.3M
POTASSIUM CHANNEL EXPRESSION IN PANCREATIC B CELLSR01DK048494 · NIDDK · UNIVERSITY OF CHICAGO · PI PHILIPSON, LOUIS H. · 1995 to 2011
$2.8M
SysCODE Interdisciplinary postdoctoral Training Grant (8 of 10)RL9RL9EB008539 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2007 to 2011
$1.2M
NCATS NIH HHS UL1 TR000430NIBIB NIH HHS 1RL9EB008539-01NIBIB NIH HHS RL9 EB008539NIDA NIH HHS DA05084NIDA NIH HHS R01 DA005084NIDA NIH HHS R56 DA005084NIDDK NIH HHS 5P30 DK36836NIDDK NIH HHS K01 DK075706NIDDK NIH HHS K99 DK090210NIDDK NIH HHS KO1 DK075706-01A1NIDDK NIH HHS P01 DK049210NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R00 DK090210NIDDK NIH HHS R01 DK 048494NIDDK NIH HHS R01 DK048494NIDDK NIH HHS R01 DK 049703NIDDK NIH HHS R01 DK049703NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK068157NIDDK NIH HHS R01 DK67536
6 · The paper itself

Abstract

Insulin resistance, hyperinsulinemia, and hyperproinsulinemia occur early in the pathogenesis of type 2 diabetes (T2D). Elevated levels of proinsulin and proinsulin intermediates are markers of β-cell dysfunction and are strongly associated with development of T2D in humans. However, the mechanism(s) underlying β-cell dysfunction leading to hyperproinsulinemia is poorly understood. Here, we show that disruption of insulin receptor (IR) expression in β cells has a direct impact on the expression of the convertase enzyme carboxypeptidase E (CPE) by inhibition of the eukaryotic translation initiation factor 4 gamma 1 translation initiation complex scaffolding protein that is mediated by the key transcription factors pancreatic and duodenal homeobox 1 and sterol regulatory element-binding protein 1, together leading to poor proinsulin processing. Reexpression of IR or restoring CPE expression each independently reverses the phenotype. Our results reveal the identity of key players that establish a previously unknown link between insulin signaling, translation initiation, and proinsulin processing, and provide previously unidentified mechanistic insight into the development of hyperproinsulinemia in insulin-resistant states.

Indexed as

AnimalsCarboxypeptidase HCells, CulturedDiabetes Mellitus, Type 2Endoplasmic Reticulum StressEukaryotic Initiation Factor-4GGenome-Wide Association StudyHomeodomain ProteinsHumansInsulinInsulin-Secreting CellsMaleMiceMice, Inbred C57BLMice, KnockoutProtein BiosynthesisCarboxypeptidase HEIF4G1 protein, humanEif4g1 protein, mouseEukaryotic Initiation Factor-4GHomeodomain ProteinsInsulinpancreatic and duodenal homeobox 1 proteinReceptor, InsulinSREBF1 protein, humanSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1Trans-ActivatorsbIRKOER stressGWASprohormone

Identifiers

PMID24843127
PMCPMC4050564
OpenAlexW2029236123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.